TNI medical
Develops, produces, and sells devices for respiratory therapy.
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 19 % | - | - | - | 337 % | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (71 %) | - | - | (86 %) | (7 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
TNI medical AG, established in 2007, specializes in developing and providing Nasal Highflow (NHF) therapy systems, particularly the TNI softFlow series. These systems are designed to improve respiratory function in adults under clinical care. The company operates within the medical device market, focusing on respiratory therapy solutions. TNI medical AG primarily serves hospitals, clinics, and healthcare providers who require advanced respiratory support for their patients. The business model revolves around the sale and distribution of its NHF therapy systems, generating revenue through direct sales and service contracts. The company's pioneering research and development efforts have positioned it as a standard-bearer in the NHF therapy sector.
Keywords: NHF therapy, respiratory function, clinical care, TNI softFlow, medical devices, healthcare providers, respiratory support, pioneering research, therapy systems, TNI medical AG.